Oakley Capital Investments Ltd on Tuesday said it has taken part in an investment in a service provider to the life sciences industry.
The private equity firm specialising in the technology, consumer, education and business services sectors said Oakley Capital Fund V has agreed to invest into ProductLife Group, a European provider of outsourced regulatory and compliance services to the global life sciences industry.
Oakley Capital Investments expects its own commitment via Fund V to be around £41 million.
ProductLife Chief Executive Officer Xavier Duburcq said: ‘We see tremendous opportunity to expand our business in the fragmented pharma services market both organically but also through acquisitions. Oakley has significant expertise executing buy-and-build and internationalisation strategies and we welcome the opportunity to collaborate with them on the next stage of ProductLife Group’s journey.’
Oakley Capital Founder & Managing Partner Peter Dubens said: ‘We’re pleased to be investing in ProductLife Group. This is an attractive business in a large, non-cyclical market where increased regulation and outsourcing are driving growth. At the same time, the group’s investments in technology enablement are expected to drive competitive advantages in the coming years. We look forward to working with Xavier and his management team to take full advantage of this potential.’
Oakley Capital Investments shares were 0.1% lower at 487.50 pence each on Tuesday morning in London.
Copyright 2024 Alliance News Ltd. All Rights Reserved.
